case report | Q2782326 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1011483748 |
P356 | DOI | 10.1186/S12883-016-0578-3 |
P932 | PMC publication ID | 4845487 |
P698 | PubMed publication ID | 27113444 |
P50 | author | Suzan A Alkhater | Q87378956 |
P2093 | author name string | Suzan A AlKhater | |
P2860 | cites work | Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions? | Q53651845 |
Childhood stroke as the presentation of Takayasu's arteritis: diagnostic delay can cause catastrophic complications | Q81403655 | ||
Hemorrhage predisposing to cerebral infarction in children with moyamoya disease | Q83221312 | ||
Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation | Q84561200 | ||
Emergency management of ischemic stroke in children | Q87079970 | ||
Combined immunodeficiency associated with DOCK8 mutations | Q24622094 | ||
15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation | Q24645794 | ||
Moyamoya disease and syndromes: from genetics to clinical management | Q28086795 | ||
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder | Q28138040 | ||
STAT3 mutations in the hyper-IgE syndrome | Q28249785 | ||
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection | Q28249820 | ||
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity | Q28272650 | ||
Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome | Q33639830 | ||
Mycophenolate mofetil and its mechanisms of action | Q33957177 | ||
Dedicator of cytokinesis 8 (DOCK8) deficiency | Q34139747 | ||
Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity | Q34289747 | ||
Immunodeficiencies with autoimmune consequences. | Q36472057 | ||
A review on the vascular features of the hyperimmunoglobulin E syndrome | Q37632481 | ||
DOCK8 deficiency. | Q37974982 | ||
Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review | Q38072386 | ||
Autoimmunity in immunodeficiency | Q38099528 | ||
Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. | Q38592815 | ||
Approach to the child with recurrent infections | Q41873824 | ||
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study | Q42871236 | ||
Neuroimaging, biochemical and cellular evidence of protection by mycophenolate mofetil on middle cerebral artery occlusion induced injury in rats. | Q44006868 | ||
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression | Q44562160 | ||
The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures. | Q44574080 | ||
Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients | Q44625632 | ||
Brain abnormalities in patients with hyperimmunoglobulin E syndrome | Q48200725 | ||
P304 | page(s) | 54 | |
P577 | publication date | 2016-04-26 | |
P1433 | published in | BMC Neurology | Q15763734 |
P1476 | title | CNS vasculitis and stroke as a complication of DOCK8 deficiency: a case report | |
P478 | volume | 16 |
Q91936259 | A novel mutation in NCF2 resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease |
Q39381359 | DOCK8 deficiency: Insights into pathophysiology, clinical features and management. |
Q90628053 | Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome |
Q44231695 | New onset refractory status epilepticus due to primary angiitis of the central nervous system. |
Q64902515 | The Role of Mast Cells in Stroke. |
Search more.